eXeX, an Orlando, FL-based med tech company utilizing artificial intelligence and spatial computing to optimize surgical procedures, raised $5.8M in Seed funding.
Backers were not disclosed.
The company intends to use the funds to accelerate the development of the platform and support its upcoming commercial debut.
Led by CEO Dr. Robert Masson, eXeX has built a platform that allows surgical teams to onboard staff and complete surgical procedures with increased efficiency and accuracy. The company has patented its technology, which has been utilized in over 2,000 live surgeries across three continents, yielding incredible results. eXeX is set to launch commercially in early 2025, with initial availability at select hospitals across the United States and United Kingdom.
The company also announced the appointment of Michael Dykier as Chief Technology Officer (CTO).
FinSMEs
27/08/2024